Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
121 Cards in this Set
- Front
- Back
Characteristics of Azotemia |
Increased BUN and creatinine; decreased GFR |
|
Azotemia from hypoperfusion of the kidney |
Prerenal azotemia |
|
Prerenal azotemia is associated with parenchymal damage of the kidney |
False |
|
Postrenal azotemia results from? |
Obstruction of urine flow |
|
Characteristics of uremia |
Failure of renal excretory function; metabolic and endrocine alterations |
|
Cause of metabolic and endocrine alterations in uremia |
Renal damage |
|
Presentation of nephritic syndrome |
Hematuria, diminished GFR, proteinuria, and hypertension |
|
Hematuria associated with nephritic syndrome. Gross or microscopic? |
Both |
|
Urine findings in microscopic hematuria of nephritic syndrome |
Red cell casts and dysmorphic RBCs |
|
Nephritic syndrome can present with severe proteinuria |
False |
|
Characteristic of nephrotic syndrome |
Proteinuria, hypoalbuminemia, severe edema, hyperlipidemia, and lipiduria |
|
Amount of proteinuria associated with nephrotic syndrome |
>3.5 gm/day |
|
Asymptomatic mild glomarular abnormalities may present with? Hematuria or proteinuria? |
Both |
|
Characteristic of acute kidney injury |
Decreased GFR, fluid and electrolyte dysregulation, and retention of metabolic waste |
|
Severe form of acute kidney injury may present with? Oliguria or anuria? |
Both |
|
Acute kidney injury may result from? Glomerular, interstitial, tubular, or vascular injury? |
All |
|
GFR associated with chronic renal disease |
<60 ml/min/1.73 sq.m. |
|
Length of time that GFR should be diminished significantly for diagnosis of chronic renal disease |
3 months |
|
Another characteristic of chronic renal disease aside from GFR findings |
Persistent albuminuria |
|
Presentation of severe chronic renal disease |
Prolonged uremia |
|
Chronic renal disease is the end result of? |
Chronic renal parenchymal disease |
|
GFR associated with end-stage renal disease (ESRD) |
<5% of normal |
|
The terminal stage of uremia |
ESRD |
|
Manifestations of renal tubular defects |
Polyuria, nocturia, and electrolyte disorder |
|
Affected in renal tubular disease? Structure or function? |
Both |
|
Presentation of renal obstruction and tumors are affected by? |
Nature of lesion and location |
|
Characteristic of UTI? Bacteriuria or pyuria? |
Both |
|
UTI can affect what organ? Kidney or bladder? |
Both |
|
Nephrolithiasis presents with? Renal colic or hematuria? |
Both |
|
Nephrolithiasis predisposes to recurrent stone formation |
True |
|
Main systemic disorders associated with glomerular disease |
Diabetes milletus, SLE, vasculitis, and amyloidosis |
|
Podocytes. Visceral or parietal? |
Visceral |
|
Electron-lucent layer of GBM? Lamina rara externa or interna? |
Both |
|
Foot processes of podocytes adhere to? Lamina rara externa or interna? |
Externa |
|
Basement-like membrane of the glomerular tuft |
Mesangial matrix |
|
Capillary wall acts as a? Charge-dependent or size-dependent barrier? |
Both |
|
Slit diaphragm of podocytes. Size-selective or charge-selective? |
Size |
|
Pathologic responses of the glomerulus to injury |
Hypercellularity, basement membrane thickening, hyalinosis and sclerosis |
|
Cells that proliferate in hypercellularity. Mesangial or endothelial cells? |
Both |
|
Result from hypercellularity |
Proliferation, infiltration, and crescent formation |
|
Infilitrates associated with hypercellularity. Neutrophils, monocytes, or lymphocytes? |
All |
|
Component of endocapillary proliferation |
Proliferation and infiltration |
|
Predominant cells associated with formation of crescents. Parietal or visceral? |
Parietal |
|
Precedes formation of crescents |
Inflammation of capillary walls |
|
Stain used to demonstrate basement membrane thickening |
PAS (Periodic Acid Schiff) |
|
Forms of basement membrane thickening |
Deposition of electron-dense material, Increases synthesis of protein components, and formation of additional layers of GBM matrix |
|
End result of glomerular damage |
Hyalinosis |
|
Characteristic deposition in sclerosis |
Collagenous |
|
Sclerosis in diabetic glomerulosclerosis involves? Mesangial area or capillary loops? |
Mesangial area |
|
Histologic pattern involving all glomeruli. Diffuse or global? |
Diffuse |
|
Histologic pattern involving entirety of a glomerulus. Diffuse or global? |
Global |
|
Histologic pattern involving some glomeruli. Focal or segmental? |
Focal |
|
Histologic pattern involving part of a glomerulus. Focal or segmental? |
Segmental |
|
Mediated by immune mechanism. Primary or secondary glomerulopathy? |
Both |
|
Pattern of immune deposition involving in situ formations. Granular or linear? |
Granular |
|
Location of in situ complex deposition. Subendothelial or subepithelial? |
Subepithelial |
|
Basic reaction associated with in situ deposition. Hypercellularity or basement membrane thickening? |
Basement membrane thickening |
|
Disease associated with in situ complex deposition |
Membranous nephropathy |
|
Pattern of immune deposition associated with antibodies against normal GBM components. Granular or linear? |
Linear |
|
Antigens associated with circulating complex deposition. Endogenous or exogenous? |
Both |
|
Injury associated with immune complex deposition. Direct or inflammatory? |
Inflammatory |
|
Locations of immune complex deposition? Mesangium, Subendothelial, or subepithelial? |
All |
|
Location of deposition associated with immune complex formation. GBM or mesangium? |
Both |
|
Degrade immune complexes. Neutrophils, macrophage, masangial cells, or proteases? |
All |
|
Deposition of cationic molecules. Subendothelial, subepithelial, or mesangium? |
Subepithelial |
|
Deposition of anionic molecules. Subepithelial, subendothelial, or mesangium? |
Subendothelial |
|
Deposition of neutral molecules. Subendothelial, subepithelial, or mesangium |
Mesangium |
|
Deposition of large molecules. Subendothelial, subepithelial, or mesangium? |
None (Cleared by macrophages) |
|
Nephritogenic. Cationic, anionic, neutral or large molecules? |
Cationic and anionic molecules (small-sized) |
|
Pattern of deposition localization is influenced by? Hemodynamics, mesangial function, or charge-selective barrier? |
All |
|
Rate of GFR associated with independent progression to ESRD |
30-50% of normal |
|
Urine finding associated with focal segmental glomerulosclerosis |
Proteinuria |
|
Major histologic characteristics of progessive renal damage |
Focal segmental glomerulosclerosis (FSGS) and Tubulointerstitialfibrosis |
|
Manifestation of tubulointerstital fibrosis |
Tubular damage and interstitial inflammation |
|
Tubulointerstital fibrosis is a component of? Acute or chronic glomerulonephritides? |
Both |
|
What causes direct injury and activation of tubular cells in tubulointerstitial fibrosis? |
Proteinuria |
|
Characteristic of nephritic syndrome |
Glomerular inflammation |
|
Urine finding associated with nephritic syndrome |
Hematuria |
|
Acute proliferative glomerulenephritis. Nephritic or nephrotic? |
Nephritic |
|
Poststreptococcal glomerulonephritis. Nephritic or nephrotic? |
Nephritic |
|
Characteristic of acute proliferative glomerulonephritis. |
Diffuse proliferation and leukocytic infiltration |
|
Acute proliferative glomerulonephritis is causes by? |
Immune complexes |
|
Prototypical renal disease of immune etiology |
Poststreptococcal glomerulonephritis |
|
Pattern of deposition associated with poststreptococcal glomerulonephritis. Granular or linear? |
Granular |
|
Location of deposition associated with poststreptococcal glomerulonephritis. Subendothelial or subepithelial? |
Both (Subendothelial-early;Subepithelial-late) |
|
Amount of proteinuria associated with poststreptococcal glomerulonephritis. |
<1 gm/day |
|
Elevated in poststreptococcal glomerulonephritis? Antistreptococcal Ab or Serum C3 |
Antistreptococcal Ab (Serum C3 declines) |
|
Specific etiologic cause of rapid progressive glomerulonephritis (RPGN) |
None |
|
Associated with RPGN. Oliguria or nephritic syndrome? |
Both |
|
Most common histologic picture associated with RPGN |
Crescent formation |
|
Mediates glomerular injury in RPGN |
Immune mechanism |
|
Type 1 RPGN |
Anti-GBM Antibody |
|
Type 2 RPGN |
Immune complex |
|
Type 3 RPGN |
Pauci-immune |
|
Pattern of deposition associated with RPGN. Granular or linear? |
Granular |
|
Crescentic glomerulonephritis associated with pauci-immune type are associated with? Small-vessel vasculitis or polyangiitis? |
Both |
|
Nephrotic syndrome is characterized by this defect. |
Capillary wall defect |
|
Amount of proteinuria associated with nephrotic syndrome |
>3.5 gm/day |
|
Plasma protein level associated with nephrotic syndrome |
<3 gm/dL |
|
Nephrotic syndrome is associated with? Edema, Hyperlipidemia, or Lipiduria? |
All |
|
Location of deposition associated with membranous nephropathy |
Subepithelial |
|
What is contained in the depositions associated with membranous nephropathy? |
Immunoglobulins |
|
Findings in light microscopy associated with the early stage of membranous nephropathy |
None (appear normal) |
|
Findings in electron microscopy associated with membranous nephropathy. |
Electron dense deposits |
|
Granular deposits in membranous nephropathy contain? Immunoglobulins or complement? |
Both |
|
Pattern of sclerosis associated with progression of membranous nephropathy. |
Segmental |
|
Early presentation of membranous nephropathy? Nephrotic syndrome or non-nephrotic proteinuria? |
Both |
|
Urine finding associated with membranous nephropathy. |
Hematuria |
|
Characteristic of minimal change disease |
Effacement of podocytes |
|
Which can be used to diagnose minimal change disease. Light or electron microscopy? |
Electron (virtually normal using light microscopy) |
|
Urine finding associated with minimal-change disease |
Proteinuria |
|
MPGN type 1 is characterized by?
|
Immune complex deposition
|
|
MPGN type 2 is characterized by?
|
Complement activation
|
|
Charactersitic of the glomerulus in MPGN |
Hypercellular |
|
Lobular appearance of glomeruli in MPGN is due to? Mesangial cell or matrix proliferation?
|
Both
|
|
Location of deposition in IgA nephropathy
|
Mesangium
|
|
Diagnosis of IgA nephropathy uses what laboratory technique? |
Immunoflourescence |
|
Hereditary nephritis is due to what mutations?
|
Collagen mutations
|
|
Which hereditary nephritis is X-linked? Alport syndrome or Thin basement membrane disease?
|
Alport syndrome
|
|
Thin basement membrane disease. X linked, dominant, or recessive?
|
Recessive
|
|
Finding in chronic glomerulonephritis. Obliteration of glomeruli or Arterial/arteriolar sclerosis?
|
Both
|